288
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Folate, related vitamins and risk of Alzheimer’s disease

Pages 559-561 | Published online: 10 Jan 2014

References

  • Cummings JL. Alzheimer’s disease. N. Engl. J. Med.351, 56–67 (2004).
  • Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health88, 1337–1342 (1998).
  • Selkoe DJ. Alzheimer’s disease: genotypes, phenotypes, and treatments. Science275, 630–631 (1997).
  • Luchsinger J, Mayeux R. Cardiovascular risk factors and Alzheimer’s disease. Curr. Atheroscler. Rep.6, 261–266 (2004).
  • Selkoe DJ. The origins of Alzheimer disease: a is for amyloid. JAMA283, 1615–1617 (2000).
  • Luchsinger JA, Mayeux R. Dietary factors and Alzheimer’s disease. Lancet Neurol.3, 579–587 (2004).
  • Seshadri S, Beiser A, Selhub J et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N. Engl. J. Med.346, 476–483 (2002).
  • Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA270, 2693–2698 (1993).
  • Rasmussen K, Moller J, Lyngbak M, Pedersen AM, Dybkjaer L. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin. Chem.42, 630–636 (1996).
  • Seshadri S, Wolf PA. Homocysteine and the brain: vascular risk factor or neurotoxin? Lancet Neurol.2, 11 (2003).
  • Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am. J. Clin. Nutr.71, 993–998 (2000).
  • Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R. Plasma homocysteine levels and risk of Alzheimer disease. Neurology62, 1972–1976 (2004).
  • Haan MN, Miller JW, Aiello AE et al. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am. J. Clin. Nutr.85, 511–517 (2007).
  • Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimer’s disease. Neurology56, 1188–1194 (2001).
  • Crystal HA, Ortof E, Frishman WH, Gruber A, Hershman D, Aronson M. Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J. Am. Geriatr. Soc.42, 933–936 (1994).
  • Morris MC, Evans DA, Schneider JA, Tangney CC, Bienias JL, Aggarwal NT. Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer’s disease. J. Alzheimers Dis.9, 435–443 (2006).
  • Morris MC, Evans DA, Bienias JL et al. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch. Neurol.62, 641–645 (2005).
  • Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch. Neurol.64, 86–92 (2007).
  • Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N. Engl. J. Med.340, 1449–1454 (1999).
  • Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst. Rev.3, CD001056 (2001).
  • Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am. J. Clin. Nutr.85, 193–200 (2007).
  • Toole JF, Malinow MR, Chambless LE et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA291, 565–575 (2004).
  • Wang X, Qin X, Demirtas H et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet369, 1876–1882 (2007).
  • McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI, Williams SM. A controlled trial of homocysteine lowering and cognitive performance. N. Engl. J. Med.354, 2764–2772 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.